Redeye Research Interview with  Per Persson,CEO

Per Persson, gives a general update about the company's FDA application as well as the ongoing reimbursement process in Germany and the company's commercialization strategy in Europe


About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.